Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News KCI reports positive data from ABThera trial

KCI reports positive data from ABThera trial

29th August 2013

KCI has announced the publication of positive clinical trial data that underlines the potential advantages offered by ABThera, its negative pressure wound therapy system.

Results from the observational study published in the World Journal of Surgery revealed that the technology was associated with significantly improved patient outcomes compared to traditional Barker's vacuum-packing technique among trauma and surgical patients.

The ABThera open abdomen negative pressure therapy system is indicated for temporary bridging of abdominal wall openings where primary closure is not possible and repeat abdominal entries are necessary.

These trial results show the benefits of using the system as part of a comprehensive approach to open abdomen management.

Dr Ron Silverman, chief medical officer of KCI, said: "These dramatic and highly significant results underscore the value of ABThera Therapy in improving the management of patients with an open abdomen, a complex and often life-threatening condition."

This comes after the firm earlier this month launched its VAC VeraFlo Large Dressing, designed for easy application of VAC VeraFlo Instillation Therapy on larger wounds and those requiring additional dressing customisation.ADNFCR-8000103-ID-801631004-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.